Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Ablexis granted Johnson & Johnson’s Janssen Biotech Inc. unit perpetual, non-exclusive rights to use Ablexis' AlivaMab Mouse transgenic mouse platform for antibody drug discovery and development. Able...
BCIQ Company Profiles
Ablexis LLC
Johnson & Johnson